Initial qualification & authority
Profile, role, indicative volume and jurisdiction are identified, together with the authority of the seller, buyer or mandate holder.
Each file advances through controlled gates. Sensitive information is disclosed only when appropriate, and the next stage is not opened until the essential prerequisites are sufficiently met.
Profile, role, indicative volume and jurisdiction are identified, together with the authority of the seller, buyer or mandate holder.
A confidentiality framework is established. Identities and sensitive information are disclosed only when necessary for the transaction to progress.
Entity and beneficial-owner checks, sanctions and PEP screening, and risk-based AML/CFT controls appropriate to the relevant jurisdictions.
Review of available evidence relating to ownership, origin, custody, export, assay and traceability. Not every document is required at the first-contact stage.
Alignment of volume, pricing benchmark, premium or discount, destination, timing, procedure and evidence of the parties’ ability to perform.
Negotiation and execution of the applicable contractual instruments, including NDA, mandate, NCNDA/IMFPA where relevant, and the SPA or principal agreement between the parties.
Coordination of assay, refinery, insurance, secure transport, customs formalities and chain of custody in accordance with the agreed structure.
Delivery and applicable results are confirmed, settlement follows the contract, funds and agreed commissions are reconciled, and the transaction file is archived.